Winton Group LTD Sellas Life Sciences Group, Inc. Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 30, 2020	SELL	$1.88 - $3.58 $22,757 - $43,335	-12,105 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$1.53 - $3.93 $10,359 - $26,610	-6,771 Reduced 35.87%	12,105 $35,000
Q1 2020 May 11, 2020	BUY	$1.7 - $4.08 $13,314 - $31,954	7,832 Added 70.92%	18,876 $33,000
Q4 2019 Feb 13, 2020	BUY	$3.79 - $10.5 $41,856 - $115,962	11,044 New	11,044 $47,000

5.69M

1.67M

74.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $19.5M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.